Another “Globally First” from TEDA Launched
Tianjin Century Healthcare Biomedical Engineering Co., Ltd., a TEDA-based enterprise, recently announced that its independently-developed Next-Gen Trifocal Plus Intraocular Lens (IOL) officially received regulatory approval for commercialization. This innovative medical device is currently the only trifocal intraocular lens approved for market entry in China. The product features a globally pioneering proprietary technology for intelligent targeted light field distribution and adopts an asymmetric design, enabling multilevel diffraction adjustments with exceptional flexibility. Notably, it achieves a light energy utilization rate of 90% or higher, ensuring smooth, continuous vision transition across far, intermediate, and near distances for an unparalleled visual experience. Additionally, it is China's first trifocal intraocular lens designed specifically for a 60cm intermediate focus distance, catering to the visual habits and needs of Chinese patients.
Tianjin Century Healthcare Biomedical Engineering Co., Ltd. is a high-end Class III medical device manufacturer specializing in the R&D, production, and sales of intraocular lenses, optometry products, and bio-collagen materials. Recognized as a National High-Tech Enterprise, a National-Level “Little Giant” Specialized and Innovative Enterprise, and a Tianjin Gazelle Enterprise, the company has secured over 80 patents, including invention and utility model patents. It has also obtained 11 Class III and 3 Class II medical device registration certificates, with its intraocular lens products certified under CE and other international regulatory standards.
First, please LoginComment After ~